Literature DB >> 21504994

The effect of standard chow and reduced hexokinase II on growth, cardiac and skeletal muscle hexokinase and low-flow cardiac ischaemia-reperfusion injury.

Kirsten M Smeele1, Leontien H ter Horst, Anneke Koeman, Sami Heikkinen, Markku Laakso, Nina C Weber, Markus W Hollmann, Coert J Zuurbier.   

Abstract

In the present study, we examined whether standard chow (SDS versus Purina 5001; both low fat, high carbohydrate) and reductions in hexokinase (HK) II (wild-type versus HKII(+/-) mice) affect (1) growth parameters, (2) HK levels in cardiac and skeletal muscle and (3) low-flow cardiac ischaemia-reperfusion (IR) injury. Total HK activity and HKI and HKII expressions were determined, and low-flow IR injury was examined in isolated hearts subjected to 40 min 5% low-flow ischaemia and 120 min reperfusion. Standard chow, but not HKII reductions, significantly affected body weight, heart weight and cardiac hypertrophy. Both standard chow and reduced HKII diminished total cardiac and skeletal muscle HK activity. For the heart, the Purina chow-induced decrease in total HK activity was through decreases in HKI expression, whereas for skeletal muscle post-translational mechanisms are suggested. Both standard chow and reduced HKII demonstrated a non-significant trend for affecting cardiac IR damage. However, the low-flow ischaemia model was associated with mild sublethal injury only (∼1% cell death). In conclusion, standard chow affects body weight, heart weight and HK activity and HKI expression in the heart, without altering HKII expression. This implicates standard chow as an important factor in genomic, physiological research models and demonstrates that large differences in fat or carbohydrates in the diet are not necessary to affect growth. In a cardiac low-flow IR model, resulting in only mild injury, standard chow or reduced HKII does not significantly affect IR damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504994     DOI: 10.1258/la.2011.010096

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  8 in total

1.  Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.

Authors:  Ebru Gurel; Savas Ustunova; Aysegul Kapucu; Nadim Yilmazer; Otto Eerbeek; Rianne Nederlof; Markus W Hollmann; Cihan Demirci-Tansel; Coert J Zuurbier
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

Review 2.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

Review 3.  Lactate and Myocardiac Energy Metabolism.

Authors:  Shuohui Dong; Linhui Qian; Zhiqiang Cheng; Chang Chen; Kexin Wang; Sanyuan Hu; Xiang Zhang; Tongzhi Wu
Journal:  Front Physiol       Date:  2021-08-17       Impact factor: 4.755

Review 4.  Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

Authors:  Rianne Nederlof; Otto Eerbeek; Markus W Hollmann; Richard Southworth; Coert J Zuurbier
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 5.  The Pitfalls of in vivo Cardiac Physiology in Genetically Modified Mice - Lessons Learnt the Hard Way in the Creatine Kinase System.

Authors:  Craig A Lygate
Journal:  Front Physiol       Date:  2021-05-14       Impact factor: 4.566

6.  Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.

Authors:  Rianne Nederlof; Ebru Gürel-Gurevin; Otto Eerbeek; Chaoqin Xie; G Sjoerd Deijs; Moritz Konkel; Jun Hu; Nina C Weber; Cees A Schumacher; Antonius Baartscheer; Egbert G Mik; Markus W Hollmann; Fadi G Akar; Coert J Zuurbier
Journal:  J Physiol Biochem       Date:  2017-03-03       Impact factor: 4.158

Review 7.  Cardiac metabolism as a driver and therapeutic target of myocardial infarction.

Authors:  Coert J Zuurbier; Luc Bertrand; Christoph R Beauloye; Ioanna Andreadou; Marisol Ruiz-Meana; Nichlas R Jespersen; Duvaraka Kula-Alwar; Hiran A Prag; Hans Eric Botker; Maija Dambrova; Christophe Montessuit; Tuuli Kaambre; Edgars Liepinsh; Paul S Brookes; Thomas Krieg
Journal:  J Cell Mol Med       Date:  2020-05-08       Impact factor: 5.310

Review 8.  The Role of Metabolism in Heart Failure and Regeneration.

Authors:  Jiyoung Bae; Wyatt G Paltzer; Ahmed I Mahmoud
Journal:  Front Cardiovasc Med       Date:  2021-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.